Estrogen supplementation for female schizophrenics treated with atypical antipsychotics

General Hospital Psychiatry

Volumn 24, Issue 5, 2002, Pages 357-359

  Liao, Ding Lieh ^a   Chen, Hung ^a   Lee, Shin Min ^a   Tsai, Shih Jen ^b,c  

^a Pali Psychiatric Hospital   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Atypical antipsychotics; Estrogen; Menstruation; Schizophrenia

Indexed keywords

CLOZAPINE; CONJUGATED ESTROGEN; FLUVOXAMINE; LOXAPINE; NEUROLEPTIC AGENT; VALPROIC ACID;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; FEMALE; HOSPITAL PATIENT; HUMAN; MEDICAL ASSESSMENT; MENSTRUATION; ONSET AGE; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SUPPLEMENTATION; SYMPTOM; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; CHRONIC DISEASE; CLOZAPINE; DRUG SYNERGISM; ESTROGENS, CONJUGATED (USP); FEMALE; HUMANS; MIDDLE AGED; SCHIZOPHRENIA;

EID: 0036768047     PISSN: 01638343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-8343(02)00193-7     Document Type: Article

References (13)

1. Leung A., Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl. 401:2000;3-38.
2. Seeman M.V. Gender differences in schizophrenia. Can J Psychiatry. 27:1982;107-112.
3. Endo M., Daiguji M., Asano Y., Yamashita I., Takahashi S. Periodic psychosis recurring in association with menstrual cycle. J Clin Psychiatry. 39:1978;456-466.
4. Riecher-Rossler A., Hafner H., Stumbaum M., Maurer K., Schmidt R. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull. 20:1994;203-214.
5. Hallonquist J.D., Seeman M.V., Lang M., Rector N.A. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry. 33:1993;207-209.
6. Korhonen S., Saarijarvi S., Aito M. Successful estradiol treatment of psychotic symptoms in the premenstrual phase a case report. Acta Psychiatr Scand. 92:1995;237-238.
7. Kulkarni J., de Castella A., Smith D., et al. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res. 20:1996;247-252.
8. Kulkarni J., Riedel A., de Castella A.R., et al. Estrogen a potential treatment for schizophrenia. Schizophr Res. 48:2001;137-144.
9. Honigfeld G., Gillis R.D., Klett C.J. NOISE. Nurses' Observation Scale for Inpatient Evaluation. Guy W. ECDEU Assessment Manual for Psychopharmacology. 1976;265-273 National Institute of Mental Health, Rockville, Md.
10. Gordon J.H., Borison R.L., Diamond B.I. Modulation of dopamine receptor sensitivity by estrogen. Biol Psychiatry. 15:1980;389-396.
11. Vollenweider F.X., Vollenweider-Scherpenhuyzen M.F., Babler A., Vogel H., Hell D. Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action. Neuroreport. 9:1998;3897-3902.
12. Fink G., Sumner B.E., Rosie R., Grace O., Quinn J.P. Estrogen control of central neurotransmission effect on mood, mental state, and memory. Cell Mol Neurobiol. 16:1996;325-344.
13. Ahokas A., Aito M., Rimon R. Positive treatment effect of estradiol in postpartum psychosis a pilot study. J Clin Psychiatry. 61:2000;166-169.